---
title: The teratogenesis risk associated with antiseizure medication duotherapy in
  women with epilepsy
date: '2024-02-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38340680/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240211170654&v=2.18.0
source: heidelberg[Affiliation]
description: 'CONCLUSION: Leaving aside issues in relation to seizure control, our
  data suggest that it would be best to avoid using established teratogenic antiseizure
  medications (carbamazepine, valproate and topiramate) in combination with each other
  due to the increased FM risks. When combining an established teratogenic medication
  with a less teratogenic one, i.e. lamotrigine, levetiracetam or clonazepam, lamotrigine
  appears to be the safer ...'
disable_comments: true
---
CONCLUSION: Leaving aside issues in relation to seizure control, our data suggest that it would be best to avoid using established teratogenic antiseizure medications (carbamazepine, valproate and topiramate) in combination with each other due to the increased FM risks. When combining an established teratogenic medication with a less teratogenic one, i.e. lamotrigine, levetiracetam or clonazepam, lamotrigine appears to be the safer ...